SCHEMBL24677758

SCHEMBL24677758

COC(=O)c1ccccc1COc1ccc(O)c(C=O)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 2/20 0.46
LMNA P02545 2/20 0.41
TSHR P16473 1/20 0.41
ALDH1A1 P00352 4/20 0.41
CYP1A2 P05177 1/20 0.40
HSP90AA1 P07900 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
EGFR P00533 1/20 0.39
NOX4 Q9NPH5 1/20 0.39
BACE1 P56817 1/20 0.38
ERN1 O75460 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA5A P35218 1/20 0.37
CA9 Q16790 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24677759 0.89 MRGPRX4 (0.47) MRGPRX4LMNATSHRALDH1A1CYP1A2
SCHEMBL24677760 0.88 MRGPRX4 (0.46) MRGPRX4LMNATSHRALDH1A1CYP1A2
SCHEMBL30447357 0.88 MRGPRX4 (0.46) MRGPRX4LMNATSHRALDH1A1CYP1A2
SCHEMBL25950565 0.87 LMNA (0.42) MRGPRX4LMNATSHRALDH1A1CYP1A2
SCHEMBL25950573 0.81 ALDH1A1 (0.42) MRGPRX4LMNAALDH1A1CYP1A2HSP90AA1
SCHEMBL24677801 0.79 HTT (0.50) MRGPRX4ALDH1A1MAPTCYP2C9SMN1; SMN2
SCHEMBL30558899 0.79 HTT (0.50) MRGPRX4ALDH1A1MAPTCYP2C9SMN1; SMN2
SCHEMBL14691336 0.76 ALDH1A1 (0.50) LMNAALDH1A1CYP1A2HSP90AA1MAPT
SCHEMBL29831705 0.76 MRGPRX4 (0.51) MRGPRX4ALDH1A1TP53HTT
SCHEMBL24677896 0.76 MRGPRX4 (0.51) MRGPRX4ALDH1A1TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220306681-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS ELI LILLY AND COMPANY 2022-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220306681-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS NR3C1, MC2R, NR3C2 MRGPRX4 28/4885LMNA 4331/4885TSHR 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.